3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Solid Tumours
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Interventions
Gemcitabine
5
130-nm albumin-bound paclitaxel
3
Albumin-Bound Paclitaxel
2
spartalizumab
1
canakinumab
1
Taxes
1
SLC-0111
1
IFL protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metastatic Pancreatic Ductal Adenocarcinoma
×
SLC-0111
×
Clear all
NCT03450018
2024-05-24
SLC-0111-17-01
British Columbia Cancer Agency
Phase 1/2
Terminated
6 enrolled